Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endosonography | 24 | 2023 | 96 | 4.930 |
Why?
|
Endoscopy, Gastrointestinal | 14 | 2023 | 153 | 2.760 |
Why?
|
Endoscopy | 11 | 2023 | 332 | 2.240 |
Why?
|
Endoscopic Mucosal Resection | 6 | 2023 | 21 | 2.170 |
Why?
|
Esophageal Neoplasms | 11 | 2023 | 321 | 1.800 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 11 | 2023 | 62 | 1.740 |
Why?
|
Bacteria | 13 | 2021 | 447 | 1.610 |
Why?
|
Barrett Esophagus | 7 | 2023 | 93 | 1.520 |
Why?
|
Gastric Outlet Obstruction | 2 | 2021 | 10 | 1.470 |
Why?
|
Colonoscopy | 11 | 2016 | 264 | 1.420 |
Why?
|
Pancreatic Neoplasms | 13 | 2021 | 645 | 1.400 |
Why?
|
Pancreatic Diseases | 6 | 2018 | 52 | 1.390 |
Why?
|
Stomach Neoplasms | 6 | 2020 | 266 | 1.340 |
Why?
|
Deglutition Disorders | 3 | 2021 | 115 | 1.340 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2023 | 106 | 1.310 |
Why?
|
Colonic Polyps | 6 | 2015 | 126 | 1.260 |
Why?
|
Pancreatitis, Chronic | 3 | 2017 | 49 | 1.250 |
Why?
|
Esophageal Stenosis | 4 | 2023 | 26 | 1.230 |
Why?
|
Microbial Consortia | 4 | 2015 | 13 | 1.230 |
Why?
|
Adenoma | 6 | 2016 | 235 | 1.210 |
Why?
|
Endoscopy, Digestive System | 5 | 2020 | 65 | 1.190 |
Why?
|
Equipment Contamination | 3 | 2021 | 22 | 1.140 |
Why?
|
Duodenoscopes | 4 | 2023 | 7 | 1.120 |
Why?
|
Stents | 11 | 2023 | 377 | 1.110 |
Why?
|
Surgery, Computer-Assisted | 3 | 2018 | 99 | 1.090 |
Why?
|
Gastroenterology | 4 | 2021 | 134 | 1.080 |
Why?
|
Disinfection | 3 | 2021 | 14 | 1.060 |
Why?
|
Gastroenterostomy | 3 | 2021 | 7 | 1.040 |
Why?
|
Adenocarcinoma | 11 | 2021 | 1169 | 1.020 |
Why?
|
Microbiota | 11 | 2015 | 381 | 1.010 |
Why?
|
Drainage | 6 | 2023 | 157 | 1.010 |
Why?
|
Biopsy, Fine-Needle | 7 | 2011 | 93 | 0.990 |
Why?
|
Humans | 111 | 2023 | 86643 | 0.990 |
Why?
|
Cholestasis | 4 | 2019 | 47 | 0.930 |
Why?
|
Cholecystitis, Acute | 1 | 2023 | 7 | 0.910 |
Why?
|
Gallbladder | 1 | 2023 | 30 | 0.910 |
Why?
|
Fellowships and Scholarships | 3 | 2020 | 108 | 0.890 |
Why?
|
Cross Infection | 2 | 2021 | 141 | 0.870 |
Why?
|
Soil Microbiology | 5 | 2015 | 21 | 0.860 |
Why?
|
Gastrointestinal Tract | 5 | 2015 | 191 | 0.850 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2021 | 7 | 0.830 |
Why?
|
Intestinal Perforation | 1 | 2021 | 34 | 0.820 |
Why?
|
Endoscopes | 2 | 2021 | 9 | 0.820 |
Why?
|
Narrow Band Imaging | 4 | 2017 | 6 | 0.820 |
Why?
|
Metagenomics | 4 | 2014 | 83 | 0.800 |
Why?
|
Diarrhea | 2 | 2016 | 182 | 0.790 |
Why?
|
Anastomotic Leak | 4 | 2019 | 96 | 0.740 |
Why?
|
Self Expandable Metallic Stents | 2 | 2019 | 7 | 0.730 |
Why?
|
Ultrasonography, Interventional | 5 | 2020 | 121 | 0.710 |
Why?
|
Biodiversity | 6 | 2015 | 197 | 0.700 |
Why?
|
Esophagoscopy | 7 | 2023 | 87 | 0.690 |
Why?
|
RNA, Ribosomal, 16S | 11 | 2015 | 241 | 0.670 |
Why?
|
Pancreatitis | 3 | 2023 | 87 | 0.650 |
Why?
|
Observer Variation | 5 | 2015 | 602 | 0.650 |
Why?
|
Environmental Microbiology | 4 | 2015 | 22 | 0.640 |
Why?
|
Rectum | 2 | 2016 | 146 | 0.640 |
Why?
|
Bile Duct Neoplasms | 3 | 2015 | 79 | 0.630 |
Why?
|
Bacterial Physiological Phenomena | 2 | 2015 | 40 | 0.630 |
Why?
|
Environmental Monitoring | 2 | 2015 | 71 | 0.630 |
Why?
|
Colorectal Neoplasms | 5 | 2021 | 938 | 0.620 |
Why?
|
Colon | 6 | 2017 | 496 | 0.610 |
Why?
|
Abdominal Pain | 2 | 2010 | 137 | 0.610 |
Why?
|
Ecosystem | 6 | 2015 | 316 | 0.600 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 53 | 0.600 |
Why?
|
Treatment Outcome | 16 | 2023 | 7993 | 0.580 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 120 | 0.570 |
Why?
|
Male | 47 | 2023 | 40965 | 0.570 |
Why?
|
Defecation | 1 | 2016 | 23 | 0.560 |
Why?
|
Rectal Diseases | 1 | 2016 | 24 | 0.560 |
Why?
|
Nurses | 2 | 2013 | 40 | 0.550 |
Why?
|
Choristoma | 1 | 2016 | 68 | 0.540 |
Why?
|
Aged | 32 | 2020 | 18415 | 0.540 |
Why?
|
Soil | 4 | 2015 | 31 | 0.540 |
Why?
|
Microscopy, Confocal | 7 | 2017 | 268 | 0.540 |
Why?
|
Stomach | 1 | 2016 | 108 | 0.530 |
Why?
|
Abdominal Abscess | 1 | 2015 | 22 | 0.530 |
Why?
|
Escherichia coli Infections | 1 | 2015 | 35 | 0.520 |
Why?
|
Amoeba | 1 | 2015 | 5 | 0.520 |
Why?
|
Colonic Neoplasms | 4 | 2014 | 556 | 0.520 |
Why?
|
Cholangiocarcinoma | 1 | 2015 | 66 | 0.510 |
Why?
|
Gastric Mucosa | 2 | 2015 | 66 | 0.510 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 81 | 0.510 |
Why?
|
Female | 44 | 2023 | 44532 | 0.500 |
Why?
|
Needles | 2 | 2016 | 35 | 0.490 |
Why?
|
Legionella pneumophila | 1 | 2015 | 66 | 0.490 |
Why?
|
Pancreatic Cyst | 5 | 2015 | 28 | 0.480 |
Why?
|
Sphingomonadaceae | 1 | 2013 | 2 | 0.480 |
Why?
|
Middle Aged | 33 | 2021 | 25028 | 0.470 |
Why?
|
Endoscopic Ultrasound-Guided Fine Needle Aspiration | 4 | 2016 | 25 | 0.440 |
Why?
|
Accidents, Home | 1 | 2012 | 16 | 0.430 |
Why?
|
Hospitals | 1 | 2015 | 294 | 0.430 |
Why?
|
Dissection | 3 | 2017 | 42 | 0.410 |
Why?
|
Mass Screening | 2 | 2013 | 618 | 0.410 |
Why?
|
Geologic Sediments | 3 | 2014 | 19 | 0.400 |
Why?
|
Carbon | 3 | 2015 | 80 | 0.390 |
Why?
|
Interleukin-10 | 3 | 2015 | 149 | 0.390 |
Why?
|
Prospective Studies | 10 | 2021 | 4213 | 0.390 |
Why?
|
Archaea | 2 | 2014 | 18 | 0.380 |
Why?
|
Bacterial Infections | 1 | 2012 | 182 | 0.370 |
Why?
|
Petroleum Pollution | 2 | 2014 | 11 | 0.370 |
Why?
|
Diagnostic Imaging | 2 | 2013 | 469 | 0.360 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2015 | 549 | 0.360 |
Why?
|
Aged, 80 and over | 14 | 2020 | 6509 | 0.350 |
Why?
|
Gastrointestinal Diseases | 2 | 2013 | 146 | 0.350 |
Why?
|
Postoperative Complications | 3 | 2018 | 2207 | 0.350 |
Why?
|
Metagenome | 4 | 2014 | 102 | 0.350 |
Why?
|
Pancreatitis, Acute Necrotizing | 2 | 2021 | 16 | 0.350 |
Why?
|
Lymphoma | 1 | 2011 | 262 | 0.350 |
Why?
|
Retrospective Studies | 14 | 2023 | 8489 | 0.340 |
Why?
|
Biliary Tract Neoplasms | 2 | 2020 | 33 | 0.320 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2020 | 70 | 0.320 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2007 | 9 | 0.310 |
Why?
|
Esophagitis, Peptic | 1 | 2007 | 10 | 0.310 |
Why?
|
Video Recording | 3 | 2020 | 190 | 0.310 |
Why?
|
Developing Countries | 1 | 2007 | 71 | 0.290 |
Why?
|
Food | 1 | 2007 | 86 | 0.290 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2007 | 64 | 0.290 |
Why?
|
Tomography, Optical Coherence | 2 | 2019 | 130 | 0.280 |
Why?
|
Hydrogen | 2 | 2014 | 47 | 0.280 |
Why?
|
Sigmoidoscopy | 1 | 2006 | 36 | 0.280 |
Why?
|
Inflammation | 3 | 2015 | 920 | 0.280 |
Why?
|
Mucin-2 | 1 | 2015 | 12 | 0.270 |
Why?
|
Life | 1 | 2014 | 7 | 0.260 |
Why?
|
DNA, Bacterial | 4 | 2015 | 236 | 0.260 |
Why?
|
Acetobacterium | 1 | 2014 | 1 | 0.260 |
Why?
|
Biota | 2 | 2014 | 19 | 0.260 |
Why?
|
Antioxidants | 2 | 2014 | 223 | 0.250 |
Why?
|
Acetates | 1 | 2014 | 66 | 0.250 |
Why?
|
Ascorbic Acid | 1 | 2004 | 37 | 0.250 |
Why?
|
Plant Preparations | 1 | 2004 | 19 | 0.250 |
Why?
|
Adenomatous Polyps | 2 | 2015 | 11 | 0.250 |
Why?
|
Acetic Acid | 1 | 2014 | 8 | 0.250 |
Why?
|
Intestinal Polyps | 2 | 2015 | 26 | 0.250 |
Why?
|
Biopsy | 5 | 2019 | 1163 | 0.250 |
Why?
|
Equipment Design | 5 | 2015 | 406 | 0.250 |
Why?
|
Sulfates | 1 | 2014 | 56 | 0.240 |
Why?
|
Ciona intestinalis | 1 | 2014 | 25 | 0.240 |
Why?
|
Cannabis | 1 | 2014 | 34 | 0.240 |
Why?
|
Enterobacter cloacae | 2 | 2021 | 8 | 0.240 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.240 |
Why?
|
Veterans | 1 | 2004 | 72 | 0.240 |
Why?
|
Dexamethasone | 1 | 2015 | 326 | 0.230 |
Why?
|
Biliary Tract Diseases | 2 | 2013 | 34 | 0.230 |
Why?
|
Iron | 1 | 2014 | 164 | 0.230 |
Why?
|
Klebsiella pneumoniae | 2 | 2021 | 34 | 0.230 |
Why?
|
Adult | 21 | 2023 | 25648 | 0.230 |
Why?
|
Phytotherapy | 1 | 2004 | 133 | 0.230 |
Why?
|
Hepatitis C, Chronic | 1 | 2004 | 126 | 0.220 |
Why?
|
Precancerous Conditions | 2 | 2023 | 196 | 0.220 |
Why?
|
Pregnancy Complications | 1 | 2006 | 336 | 0.220 |
Why?
|
Clinical Competence | 2 | 2020 | 751 | 0.220 |
Why?
|
Surveys and Questionnaires | 5 | 2021 | 2501 | 0.210 |
Why?
|
Carbon Dioxide | 3 | 2015 | 188 | 0.210 |
Why?
|
Internet | 2 | 2021 | 312 | 0.200 |
Why?
|
Sequence Analysis, RNA | 1 | 2013 | 217 | 0.200 |
Why?
|
Quality of Life | 2 | 2021 | 1585 | 0.200 |
Why?
|
Gastroesophageal Reflux | 1 | 2023 | 117 | 0.200 |
Why?
|
Chi-Square Distribution | 3 | 2012 | 364 | 0.200 |
Why?
|
Mentoring | 1 | 2021 | 30 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2018 | 1313 | 0.190 |
Why?
|
Lifting | 1 | 2020 | 12 | 0.190 |
Why?
|
Videoconferencing | 1 | 2020 | 16 | 0.190 |
Why?
|
Cohort Studies | 5 | 2019 | 2767 | 0.190 |
Why?
|
Databases, Factual | 3 | 2019 | 814 | 0.190 |
Why?
|
Nitrogen | 3 | 2015 | 70 | 0.190 |
Why?
|
Prosthesis Failure | 2 | 2019 | 111 | 0.180 |
Why?
|
Teaching Rounds | 1 | 2020 | 24 | 0.180 |
Why?
|
Intestinal Mucosa | 2 | 2015 | 797 | 0.180 |
Why?
|
Clinical Clerkship | 1 | 2021 | 116 | 0.180 |
Why?
|
Biodegradation, Environmental | 2 | 2014 | 17 | 0.180 |
Why?
|
Host-Pathogen Interactions | 3 | 2014 | 231 | 0.180 |
Why?
|
Culture Techniques | 2 | 2016 | 91 | 0.180 |
Why?
|
Portal Vein | 2 | 2020 | 120 | 0.180 |
Why?
|
Image Enhancement | 2 | 2014 | 563 | 0.170 |
Why?
|
United States | 9 | 2021 | 6672 | 0.170 |
Why?
|
Gastrectomy | 1 | 2019 | 68 | 0.170 |
Why?
|
Simulation Training | 1 | 2020 | 88 | 0.170 |
Why?
|
Gastrointestinal Microbiome | 1 | 2015 | 455 | 0.170 |
Why?
|
Genome, Bacterial | 2 | 2014 | 139 | 0.170 |
Why?
|
Glucuronosyltransferase | 1 | 2020 | 184 | 0.170 |
Why?
|
HIV Infections | 1 | 2007 | 772 | 0.160 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2020 | 185 | 0.160 |
Why?
|
Cardia | 1 | 2017 | 5 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 1076 | 0.150 |
Why?
|
Obesity | 2 | 2014 | 963 | 0.150 |
Why?
|
Seawater | 2 | 2014 | 43 | 0.150 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 3030 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
RNA, Bacterial | 2 | 2015 | 108 | 0.150 |
Why?
|
Electrocoagulation | 2 | 2013 | 22 | 0.150 |
Why?
|
Capsule Endoscopes | 2 | 2013 | 5 | 0.150 |
Why?
|
Sclerotherapy | 2 | 2013 | 16 | 0.150 |
Why?
|
Temperature | 2 | 2015 | 396 | 0.150 |
Why?
|
Attitude to Health | 1 | 2018 | 220 | 0.140 |
Why?
|
Registries | 2 | 2019 | 702 | 0.140 |
Why?
|
Breast Neoplasms | 1 | 2010 | 2903 | 0.140 |
Why?
|
Bariatric Surgery | 1 | 2019 | 194 | 0.140 |
Why?
|
Hemostasis, Endoscopic | 2 | 2016 | 15 | 0.140 |
Why?
|
Duodenal Neoplasms | 1 | 2016 | 19 | 0.140 |
Why?
|
Perception | 2 | 2018 | 168 | 0.140 |
Why?
|
Plasmids | 2 | 2014 | 287 | 0.140 |
Why?
|
Esophageal Diseases | 2 | 2013 | 26 | 0.140 |
Why?
|
Duodenoscopy | 1 | 2015 | 8 | 0.140 |
Why?
|
Palliative Care | 1 | 2017 | 257 | 0.130 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 121 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 238 | 0.130 |
Why?
|
Ventilation | 1 | 2015 | 7 | 0.130 |
Why?
|
Fiber Optic Technology | 1 | 2015 | 35 | 0.130 |
Why?
|
Grassland | 1 | 2015 | 6 | 0.130 |
Why?
|
Poaceae | 1 | 2015 | 19 | 0.130 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 930 | 0.130 |
Why?
|
Polyphenols | 1 | 2014 | 13 | 0.130 |
Why?
|
Duodenum | 1 | 2015 | 100 | 0.130 |
Why?
|
Ammonium Compounds | 1 | 2014 | 8 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Photochemotherapy | 1 | 2015 | 97 | 0.130 |
Why?
|
Humidity | 1 | 2015 | 89 | 0.130 |
Why?
|
Predictive Value of Tests | 6 | 2015 | 1673 | 0.130 |
Why?
|
Triticum | 1 | 2014 | 32 | 0.130 |
Why?
|
Esophagus | 3 | 2013 | 102 | 0.130 |
Why?
|
Satellite Imagery | 1 | 2014 | 3 | 0.130 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2014 | 8 | 0.130 |
Why?
|
Dietary Fiber | 1 | 2014 | 43 | 0.130 |
Why?
|
Water Microbiology | 1 | 2014 | 13 | 0.130 |
Why?
|
Household Articles | 1 | 2014 | 15 | 0.130 |
Why?
|
Bronchi | 1 | 2015 | 229 | 0.130 |
Why?
|
Oceans and Seas | 1 | 2014 | 30 | 0.130 |
Why?
|
Ecology | 1 | 2015 | 74 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 456 | 0.120 |
Why?
|
Epsilonproteobacteria | 1 | 2014 | 3 | 0.120 |
Why?
|
Optical Imaging | 1 | 2014 | 48 | 0.120 |
Why?
|
Alteromonadaceae | 1 | 2014 | 2 | 0.120 |
Why?
|
Wine | 1 | 2014 | 5 | 0.120 |
Why?
|
Groundwater | 1 | 2014 | 10 | 0.120 |
Why?
|
Gammaproteobacteria | 1 | 2014 | 5 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 263 | 0.120 |
Why?
|
Practice Patterns, Physicians' | 1 | 2019 | 582 | 0.120 |
Why?
|
Proctoscopes | 1 | 2013 | 1 | 0.120 |
Why?
|
Air Pollution, Indoor | 1 | 2015 | 63 | 0.120 |
Why?
|
Hemorrhoids | 1 | 2013 | 5 | 0.120 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
Viruses | 1 | 2014 | 78 | 0.120 |
Why?
|
Virulence | 1 | 2015 | 271 | 0.120 |
Why?
|
Information Systems | 1 | 2013 | 29 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2013 | 16 | 0.120 |
Why?
|
Cyanoacrylates | 1 | 2013 | 5 | 0.120 |
Why?
|
Overweight | 1 | 2014 | 118 | 0.120 |
Why?
|
Electrosurgery | 1 | 2013 | 9 | 0.120 |
Why?
|
Ants | 1 | 2014 | 47 | 0.120 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 853 | 0.120 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2013 | 15 | 0.120 |
Why?
|
Electric Power Supplies | 1 | 2013 | 9 | 0.120 |
Why?
|
Mediastinal Diseases | 1 | 2013 | 21 | 0.120 |
Why?
|
Gene Transfer, Horizontal | 1 | 2013 | 35 | 0.120 |
Why?
|
Digestive System Diseases | 1 | 2013 | 18 | 0.120 |
Why?
|
Esophageal and Gastric Varices | 1 | 2013 | 33 | 0.120 |
Why?
|
Nutritional Status | 1 | 2013 | 83 | 0.120 |
Why?
|
Tissue Adhesives | 1 | 2013 | 23 | 0.120 |
Why?
|
Odorants | 1 | 2014 | 70 | 0.120 |
Why?
|
Cyst Fluid | 1 | 2013 | 3 | 0.120 |
Why?
|
Thrombin | 1 | 2013 | 61 | 0.120 |
Why?
|
Dilatation | 1 | 2013 | 48 | 0.120 |
Why?
|
Ampulla of Vater | 1 | 2013 | 22 | 0.120 |
Why?
|
Laser Coagulation | 1 | 2013 | 54 | 0.120 |
Why?
|
Capsule Endoscopy | 1 | 2013 | 33 | 0.120 |
Why?
|
Fungi | 1 | 2013 | 65 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 116 | 0.110 |
Why?
|
Carcinoembryonic Antigen | 1 | 2013 | 41 | 0.110 |
Why?
|
Oxidation-Reduction | 3 | 2014 | 373 | 0.110 |
Why?
|
Genotype | 2 | 2020 | 1851 | 0.110 |
Why?
|
Precision Medicine | 1 | 2017 | 395 | 0.110 |
Why?
|
India | 1 | 2013 | 120 | 0.110 |
Why?
|
Feces | 3 | 2015 | 319 | 0.110 |
Why?
|
Insufflation | 1 | 2013 | 10 | 0.110 |
Why?
|
Catheter Ablation | 1 | 2015 | 233 | 0.110 |
Why?
|
Japan | 1 | 2013 | 307 | 0.110 |
Why?
|
Environmental Pollutants | 1 | 2013 | 51 | 0.110 |
Why?
|
Hemostatics | 1 | 2013 | 56 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2013 | 229 | 0.110 |
Why?
|
Saliva | 1 | 2014 | 122 | 0.110 |
Why?
|
Smell | 1 | 2014 | 109 | 0.110 |
Why?
|
Risk Factors | 5 | 2018 | 5417 | 0.110 |
Why?
|
Pakistan | 1 | 2012 | 15 | 0.110 |
Why?
|
Bile Duct Diseases | 1 | 2012 | 22 | 0.110 |
Why?
|
Hospitals, Private | 1 | 2012 | 4 | 0.110 |
Why?
|
Plethysmography, Impedance | 1 | 2012 | 4 | 0.110 |
Why?
|
Family | 1 | 2014 | 311 | 0.110 |
Why?
|
Esophageal pH Monitoring | 1 | 2012 | 12 | 0.110 |
Why?
|
Wound Closure Techniques | 1 | 2012 | 14 | 0.110 |
Why?
|
Bile Ducts | 1 | 2012 | 59 | 0.110 |
Why?
|
Manometry | 1 | 2012 | 43 | 0.110 |
Why?
|
Young Adult | 6 | 2019 | 5976 | 0.110 |
Why?
|
Logistic Models | 2 | 2007 | 1186 | 0.100 |
Why?
|
Light | 2 | 2010 | 289 | 0.100 |
Why?
|
Severity of Illness Index | 1 | 2017 | 1801 | 0.100 |
Why?
|
Genomics | 1 | 2017 | 720 | 0.100 |
Why?
|
Cystadenoma, Serous | 1 | 2011 | 15 | 0.100 |
Why?
|
Feeding Behavior | 1 | 2014 | 324 | 0.100 |
Why?
|
Jaundice, Obstructive | 1 | 2011 | 10 | 0.100 |
Why?
|
Pancreatic Ducts | 1 | 2011 | 26 | 0.100 |
Why?
|
Critical Illness | 1 | 2014 | 294 | 0.100 |
Why?
|
Chicago | 4 | 2020 | 1379 | 0.100 |
Why?
|
Prevalence | 2 | 2007 | 1239 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2013 | 105 | 0.100 |
Why?
|
Water | 1 | 2013 | 277 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 268 | 0.100 |
Why?
|
Computer Simulation | 1 | 2015 | 1078 | 0.100 |
Why?
|
Seasons | 1 | 2012 | 223 | 0.100 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 100 | 0.100 |
Why?
|
Anxiety | 1 | 2013 | 287 | 0.100 |
Why?
|
Animals | 8 | 2015 | 26582 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 295 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2015 | 502 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 425 | 0.090 |
Why?
|
Carcinoma | 1 | 2014 | 436 | 0.090 |
Why?
|
Patient Preference | 1 | 2011 | 105 | 0.090 |
Why?
|
Conscious Sedation | 2 | 2011 | 64 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2015 | 1939 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2011 | 1565 | 0.090 |
Why?
|
Infant | 2 | 2013 | 3046 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 1991 | 0.090 |
Why?
|
Constriction, Pathologic | 3 | 2016 | 213 | 0.090 |
Why?
|
Age of Onset | 1 | 2010 | 310 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2014 | 493 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2011 | 328 | 0.080 |
Why?
|
Metals | 3 | 2016 | 90 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2015 | 751 | 0.080 |
Why?
|
Pediatrics | 1 | 2012 | 344 | 0.080 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2007 | 4 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2015 | 1805 | 0.080 |
Why?
|
Bacterial Proteins | 1 | 2014 | 864 | 0.080 |
Why?
|
Anti-Ulcer Agents | 1 | 2007 | 22 | 0.080 |
Why?
|
Communication | 1 | 2011 | 441 | 0.080 |
Why?
|
Asthma | 1 | 2015 | 955 | 0.080 |
Why?
|
Tropical Climate | 1 | 2007 | 31 | 0.080 |
Why?
|
Africa | 1 | 2007 | 98 | 0.080 |
Why?
|
Asia | 1 | 2007 | 95 | 0.080 |
Why?
|
Proton Pump Inhibitors | 1 | 2007 | 31 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 144 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 307 | 0.070 |
Why?
|
Adolescent | 3 | 2019 | 8981 | 0.070 |
Why?
|
Disease Progression | 2 | 2023 | 1531 | 0.070 |
Why?
|
Catheterization | 1 | 2007 | 232 | 0.070 |
Why?
|
Base Sequence | 2 | 2014 | 2330 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2011 | 610 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 865 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2015 | 1924 | 0.070 |
Why?
|
Child, Preschool | 1 | 2012 | 3612 | 0.070 |
Why?
|
Radiography | 1 | 2007 | 813 | 0.070 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2015 | 147 | 0.070 |
Why?
|
Computer Systems | 2 | 2019 | 79 | 0.060 |
Why?
|
Plastics | 2 | 2016 | 7 | 0.060 |
Why?
|
Echinacea | 1 | 2004 | 2 | 0.060 |
Why?
|
Germ-Free Life | 1 | 2014 | 69 | 0.060 |
Why?
|
Rhizosphere | 1 | 2014 | 2 | 0.060 |
Why?
|
Operative Time | 2 | 2015 | 127 | 0.060 |
Why?
|
Pacific Ocean | 1 | 2014 | 16 | 0.060 |
Why?
|
Electrodes | 1 | 2014 | 78 | 0.060 |
Why?
|
Desulfotomaculum | 1 | 2014 | 1 | 0.060 |
Why?
|
Comamonadaceae | 1 | 2014 | 2 | 0.060 |
Why?
|
Deltaproteobacteria | 1 | 2014 | 2 | 0.060 |
Why?
|
Clostridium | 1 | 2014 | 21 | 0.060 |
Why?
|
Cannabinoids | 1 | 2014 | 12 | 0.060 |
Why?
|
Time Factors | 3 | 2014 | 5210 | 0.060 |
Why?
|
Molecular Sequence Annotation | 1 | 2014 | 67 | 0.060 |
Why?
|
Pregnancy Outcome | 1 | 2006 | 247 | 0.060 |
Why?
|
California | 1 | 2014 | 138 | 0.060 |
Why?
|
Gene Library | 1 | 2014 | 130 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 376 | 0.060 |
Why?
|
Tertiary Care Centers | 2 | 2015 | 94 | 0.060 |
Why?
|
Bacteroidetes | 1 | 2014 | 37 | 0.060 |
Why?
|
Plant Roots | 1 | 2014 | 106 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2014 | 155 | 0.060 |
Why?
|
Larva | 1 | 2014 | 118 | 0.060 |
Why?
|
Freezing | 1 | 2013 | 33 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 3092 | 0.060 |
Why?
|
DNA, Ribosomal | 1 | 2013 | 44 | 0.060 |
Why?
|
DNA Primers | 1 | 2014 | 543 | 0.060 |
Why?
|
Cold Temperature | 1 | 2013 | 157 | 0.060 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2014 | 273 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 927 | 0.060 |
Why?
|
Systems Biology | 1 | 2013 | 42 | 0.050 |
Why?
|
Panax | 1 | 2004 | 170 | 0.050 |
Why?
|
Metabolomics | 1 | 2013 | 68 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 339 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2015 | 482 | 0.050 |
Why?
|
Connecticut | 2 | 2011 | 27 | 0.050 |
Why?
|
Necrosis | 1 | 2021 | 204 | 0.050 |
Why?
|
Learning Curve | 1 | 2021 | 18 | 0.050 |
Why?
|
Reference Standards | 1 | 2021 | 159 | 0.050 |
Why?
|
Child | 1 | 2012 | 6927 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2013 | 2705 | 0.050 |
Why?
|
Body Mass Index | 2 | 2014 | 770 | 0.050 |
Why?
|
Universities | 1 | 2021 | 135 | 0.050 |
Why?
|
Pilot Projects | 2 | 2013 | 839 | 0.050 |
Why?
|
Injections | 1 | 2020 | 109 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2007 | 3640 | 0.050 |
Why?
|
Pancreas | 1 | 2021 | 239 | 0.050 |
Why?
|
Salaries and Fringe Benefits | 1 | 2019 | 23 | 0.040 |
Why?
|
Leucovorin | 1 | 2020 | 218 | 0.040 |
Why?
|
Career Mobility | 1 | 2019 | 31 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 2261 | 0.040 |
Why?
|
Phylogeny | 1 | 2014 | 1137 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 746 | 0.040 |
Why?
|
Pregnancy | 1 | 2006 | 2894 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 266 | 0.040 |
Why?
|
Transcriptome | 1 | 2013 | 580 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 859 | 0.040 |
Why?
|
Fluorouracil | 1 | 2020 | 556 | 0.040 |
Why?
|
Career Choice | 1 | 2019 | 139 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 329 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 394 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 257 | 0.040 |
Why?
|
Models, Biological | 2 | 2014 | 1749 | 0.040 |
Why?
|
Citrobacter freundii | 1 | 2016 | 2 | 0.040 |
Why?
|
Hafnia alvei | 1 | 2016 | 2 | 0.040 |
Why?
|
Klebsiella oxytoca | 1 | 2016 | 2 | 0.040 |
Why?
|
Pseudomonas putida | 1 | 2016 | 5 | 0.040 |
Why?
|
Sphingomonas | 1 | 2016 | 4 | 0.040 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2016 | 3 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 162 | 0.040 |
Why?
|
Tissue Scaffolds | 1 | 2017 | 106 | 0.040 |
Why?
|
Mice | 2 | 2015 | 11352 | 0.040 |
Why?
|
Acinetobacter baumannii | 1 | 2016 | 26 | 0.040 |
Why?
|
Sex Factors | 1 | 2019 | 1054 | 0.030 |
Why?
|
Videotape Recording | 1 | 2016 | 47 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 143 | 0.030 |
Why?
|
Immunomagnetic Separation | 1 | 2015 | 8 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2015 | 23 | 0.030 |
Why?
|
Keratins | 1 | 2015 | 63 | 0.030 |
Why?
|
Leukocyte Common Antigens | 1 | 2015 | 46 | 0.030 |
Why?
|
Radiologists | 1 | 2016 | 46 | 0.030 |
Why?
|
Sample Size | 1 | 2016 | 130 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 112 | 0.030 |
Why?
|
Gastroenterologists | 1 | 2016 | 30 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 122 | 0.030 |
Why?
|
Urease | 1 | 2015 | 3 | 0.030 |
Why?
|
Glutamate Dehydrogenase | 1 | 2015 | 6 | 0.030 |
Why?
|
Colonoscopes | 1 | 2015 | 11 | 0.030 |
Why?
|
Nitrogen Oxides | 1 | 2015 | 14 | 0.030 |
Why?
|
Tibet | 1 | 2015 | 19 | 0.030 |
Why?
|
Cell Count | 1 | 2015 | 195 | 0.030 |
Why?
|
Eosinophilia | 1 | 2015 | 84 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2015 | 118 | 0.030 |
Why?
|
Edible Grain | 1 | 2014 | 9 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 104 | 0.030 |
Why?
|
Microbial Viability | 1 | 2014 | 31 | 0.030 |
Why?
|
Drug Resistance, Fungal | 1 | 2014 | 8 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2015 | 83 | 0.030 |
Why?
|
Beds | 1 | 2014 | 5 | 0.030 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2014 | 36 | 0.030 |
Why?
|
Tumor Burden | 1 | 2016 | 289 | 0.030 |
Why?
|
Coloring Agents | 1 | 2014 | 64 | 0.030 |
Why?
|
Staphylococcus | 1 | 2014 | 24 | 0.030 |
Why?
|
Floors and Floorcoverings | 1 | 2014 | 7 | 0.030 |
Why?
|
Pets | 1 | 2014 | 8 | 0.030 |
Why?
|
Candida albicans | 1 | 2014 | 32 | 0.030 |
Why?
|
Enterobacteriaceae | 1 | 2014 | 21 | 0.030 |
Why?
|
Equipment Reuse | 1 | 2014 | 6 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 194 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2015 | 112 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2014 | 20 | 0.030 |
Why?
|
England | 1 | 2014 | 41 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 154 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2016 | 125 | 0.030 |
Why?
|
Enterococcus | 1 | 2014 | 35 | 0.030 |
Why?
|
Foot | 1 | 2014 | 50 | 0.030 |
Why?
|
Body Composition | 1 | 2014 | 68 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 2014 | 57 | 0.030 |
Why?
|
Sulfur | 1 | 2014 | 28 | 0.030 |
Why?
|
Carbohydrates | 1 | 2014 | 47 | 0.030 |
Why?
|
Surface Properties | 1 | 2014 | 130 | 0.030 |
Why?
|
Fusobacteria | 1 | 2014 | 1 | 0.030 |
Why?
|
Proteobacteria | 1 | 2014 | 6 | 0.030 |
Why?
|
Rivers | 1 | 2014 | 17 | 0.030 |
Why?
|
Gulf of Mexico | 1 | 2014 | 5 | 0.030 |
Why?
|
Carbon Radioisotopes | 1 | 2014 | 35 | 0.030 |
Why?
|
Polycyclic Aromatic Hydrocarbons | 1 | 2014 | 11 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 71 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 40 | 0.030 |
Why?
|
Siberia | 1 | 2013 | 12 | 0.030 |
Why?
|
Geography | 1 | 2015 | 223 | 0.030 |
Why?
|
Actinobacteria | 1 | 2014 | 11 | 0.030 |
Why?
|
Genes, rRNA | 1 | 2013 | 7 | 0.030 |
Why?
|
Diathermy | 1 | 2013 | 2 | 0.030 |
Why?
|
Triglycerides | 1 | 2014 | 232 | 0.030 |
Why?
|
China | 1 | 2014 | 228 | 0.030 |
Why?
|
DNA, Ribosomal Spacer | 1 | 2013 | 17 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2014 | 66 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2014 | 48 | 0.030 |
Why?
|
Infrared Rays | 1 | 2013 | 17 | 0.030 |
Why?
|
Nose | 1 | 2014 | 94 | 0.030 |
Why?
|
Data Compression | 1 | 2013 | 5 | 0.030 |
Why?
|
Ligation | 1 | 2013 | 51 | 0.030 |
Why?
|
Microcomputers | 1 | 2013 | 26 | 0.030 |
Why?
|
Virulence Factors | 1 | 2014 | 108 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 526 | 0.030 |
Why?
|
Hemoglobins | 1 | 2014 | 179 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 74 | 0.030 |
Why?
|
Educational Measurement | 1 | 2015 | 225 | 0.030 |
Why?
|
Life Style | 1 | 2014 | 189 | 0.030 |
Why?
|
Parenteral Nutrition | 1 | 2013 | 60 | 0.030 |
Why?
|
Stomach Diseases | 1 | 2013 | 19 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 2014 | 68 | 0.030 |
Why?
|
Cryosurgery | 1 | 2013 | 41 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 429 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2015 | 679 | 0.030 |
Why?
|
Enzymes | 1 | 2013 | 47 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2015 | 178 | 0.030 |
Why?
|
Hand | 1 | 2014 | 130 | 0.030 |
Why?
|
Pancreatic Pseudocyst | 1 | 2013 | 9 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2013 | 57 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 314 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 56 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 120 | 0.030 |
Why?
|
Capnography | 1 | 2012 | 5 | 0.030 |
Why?
|
Blood Pressure Monitors | 1 | 2012 | 9 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2013 | 168 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 381 | 0.030 |
Why?
|
Air | 1 | 2013 | 62 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2013 | 153 | 0.030 |
Why?
|
Clinical Alarms | 1 | 2012 | 16 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 552 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 316 | 0.030 |
Why?
|
Abscess | 1 | 2013 | 91 | 0.030 |
Why?
|
Proteome | 1 | 2014 | 124 | 0.030 |
Why?
|
Prognosis | 1 | 2020 | 3679 | 0.030 |
Why?
|
Cholesterol | 1 | 2014 | 356 | 0.030 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2013 | 78 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 689 | 0.030 |
Why?
|
Esophageal Fistula | 1 | 2012 | 10 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2014 | 223 | 0.030 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2012 | 11 | 0.030 |
Why?
|
Oximetry | 1 | 2012 | 84 | 0.030 |
Why?
|
Proteomics | 1 | 2014 | 212 | 0.030 |
Why?
|
Fluorescein | 1 | 2011 | 16 | 0.030 |
Why?
|
Catheters | 1 | 2012 | 74 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2011 | 54 | 0.030 |
Why?
|
Quality Improvement | 1 | 2015 | 428 | 0.030 |
Why?
|
Diet | 1 | 2014 | 443 | 0.030 |
Why?
|
Intestine, Small | 1 | 2013 | 303 | 0.030 |
Why?
|
Suture Techniques | 1 | 2012 | 135 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 879 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2014 | 373 | 0.020 |
Why?
|
Models, Statistical | 1 | 2015 | 574 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 683 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2013 | 337 | 0.020 |
Why?
|
Telemedicine | 1 | 2013 | 169 | 0.020 |
Why?
|
Sepsis | 1 | 2014 | 306 | 0.020 |
Why?
|
Celiac Disease | 1 | 2013 | 203 | 0.020 |
Why?
|
Anesthesia, General | 1 | 2011 | 114 | 0.020 |
Why?
|
Electrocardiography | 1 | 2012 | 478 | 0.020 |
Why?
|
Plant Extracts | 1 | 2012 | 244 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2438 | 0.020 |
Why?
|
Cytokines | 1 | 2013 | 776 | 0.020 |
Why?
|
Gene Expression | 1 | 2014 | 1284 | 0.020 |
Why?
|
Software | 1 | 2013 | 654 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2012 | 319 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 427 | 0.020 |
Why?
|
Proteins | 1 | 2014 | 777 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 1384 | 0.020 |
Why?
|
Electroencephalography | 1 | 2012 | 709 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 2360 | 0.020 |
Why?
|
Biomarkers | 1 | 2014 | 1718 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 1036 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2013 | 1981 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2015 | 1464 | 0.020 |
Why?
|
Crohn Disease | 1 | 2013 | 730 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2013 | 2232 | 0.020 |
Why?
|
Recurrence | 1 | 2008 | 1139 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 3968 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 2601 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 3362 | 0.010 |
Why?
|